Overweight individuals, not solely those classified as obese, could soon be considered for weight-loss medication following the development of a new scientific tool. This innovation is designed to predict which people face a high risk of developing serious obesity-related complications.
Scientists behind the breakthrough suggest the tool could complement traditional body mass index (BMI) scores, offering a more accurate and personalised method to identify individuals at greater risk of conditions such as cancer and type 2 diabetes. This enhanced foresight could lead to earlier monitoring, proactive interventions – including weight-loss jabs – and ultimately, improved health outcomes for many.
